PAVmed (PAVM) Competitors $0.51 +0.01 (+2.76%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$0.51 +0.01 (+1.18%) As of 10/17/2025 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAVM vs. COCH, MODD, ECOR, PETV, DRIO, MLSS, POCI, STRR, NRXS, and CLGNShould you be buying PAVmed stock or one of its competitors? The main competitors of PAVmed include Envoy Medical (COCH), Modular Medical (MODD), electroCore (ECOR), PetVivo (PETV), DarioHealth (DRIO), Milestone Scientific (MLSS), Precision Optics (POCI), Star Equity (STRR), NeurAxis (NRXS), and CollPlant Biotechnologies (CLGN). These companies are all part of the "medical equipment" industry. PAVmed vs. Its Competitors Envoy Medical Modular Medical electroCore PetVivo DarioHealth Milestone Scientific Precision Optics Star Equity NeurAxis CollPlant Biotechnologies Envoy Medical (NASDAQ:COCH) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation. Which has better earnings & valuation, COCH or PAVM? PAVmed has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvoy Medical$220K97.87-$20.80M-$1.43-0.59PAVmed$2.99M3.72$39.79M$1.160.44 Does the media favor COCH or PAVM? In the previous week, PAVmed had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for PAVmed and 1 mentions for Envoy Medical. PAVmed's average media sentiment score of 1.00 beat Envoy Medical's score of 0.91 indicating that PAVmed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envoy Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PAVmed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, COCH or PAVM? Envoy Medical has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500. Comparatively, PAVmed has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500. Do analysts prefer COCH or PAVM? Envoy Medical currently has a consensus price target of $9.50, indicating a potential upside of 1,032.57%. PAVmed has a consensus price target of $20.00, indicating a potential upside of 3,844.77%. Given PAVmed's stronger consensus rating and higher possible upside, analysts clearly believe PAVmed is more favorable than Envoy Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envoy Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00PAVmed 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 Do institutionals & insiders believe in COCH or PAVM? 8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 19.9% of PAVmed shares are owned by institutional investors. 58.9% of Envoy Medical shares are owned by insiders. Comparatively, 7.3% of PAVmed shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is COCH or PAVM more profitable? PAVmed has a net margin of 7,144.80% compared to Envoy Medical's net margin of -10,961.26%. Company Net Margins Return on Equity Return on Assets Envoy Medical-10,961.26% N/A -236.14% PAVmed 7,144.80%N/A -20.96% SummaryPAVmed beats Envoy Medical on 12 of the 15 factors compared between the two stocks. Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PAVM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAVM vs. The Competition Export to ExcelMetricPAVmedMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.82M$7.03B$6.09B$10.49BDividend YieldN/A1.17%5.73%4.80%P/E Ratio0.4427.3484.7527.11Price / Sales3.7227.65519.29179.59Price / CashN/A21.9637.1661.22Price / Book-0.555.1512.246.52Net Income$39.79M$179.79M$3.33B$276.84M7 Day Performance3.77%0.20%1.19%1.95%1 Month Performance21.55%1.24%6.18%2.21%1 Year Performance-51.25%1.67%59.89%34.06% PAVmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAVMPAVmed4.6066 of 5 stars$0.51+2.8%$20.00+3,844.8%-50.8%$10.82M$2.99M0.4490Positive NewsShort Interest ↓Gap UpCOCHEnvoy Medical2.0262 of 5 stars$1.80+123.4%$9.25+413.3%-69.3%$38.78M$222K-1.2634High Trading VolumeMODDModular Medical1.11 of 5 stars$0.69+0.8%N/A-73.1%$37.97MN/A-1.3520Analyst ForecastShort Interest ↓Gap UpECORelectroCore2.2852 of 5 stars$4.95-1.2%$25.50+415.2%-37.8%$37.53M$27.70M-3.0550PETVPetVivoN/A$1.23-3.9%N/A+136.9%$36.02M$1.05M-2.7320News CoverageGap DownDRIODarioHealth2.0662 of 5 stars$15.97-2.4%$40.00+150.5%-36.7%$35.50M$27.04M-1.18200Gap DownMLSSMilestone Scientific2.0448 of 5 stars$0.45-0.4%$1.25+179.6%-46.0%$35.12M$9.08M-6.3830Short Interest ↑Gap DownPOCIPrecision Optics0.2324 of 5 stars$4.35-0.9%N/A-1.4%$33.15M$19.09M-5.1280STRRStar Equity1.1095 of 5 stars$11.71-0.8%$5.00-57.3%+180.0%$32.32M$140.06M-9.011,300Positive NewsNRXSNeurAxis1.9878 of 5 stars$3.11-2.2%$7.00+125.0%+2.7%$30.72M$3.22M-1.6919Gap DownCLGNCollPlant Biotechnologies1.9301 of 5 stars$2.36-1.1%$11.50+388.3%-45.8%$29.93M$2.40M-2.0870News CoverageGap Up Related Companies and Tools Related Companies Envoy Medical Competitors Modular Medical Competitors electroCore Competitors PetVivo Competitors DarioHealth Competitors Milestone Scientific Competitors Precision Optics Competitors Star Equity Competitors NeurAxis Competitors CollPlant Biotechnologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAVM) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredBankrupt to billionaire after retirement?Expert Reveals: The #1 Retirement Play for 2025 "We're Entering the Greatest Energy Bull Market Since the I...Brownstone Research | SponsoredNvidia CEO’s Regret: ‘I Wish I Gave [Elon] More’…Earlier this year I predicted that the only reason Elon was in Washington was to push an AI-first agenda. Sinc...Altimetry | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
